Patent · US Active

Methods and systems for screening therapeutic compositions for treating age-related macular degeneration

US11927590B2 · kind B2 · utility

0Cited by
0References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 11, 2021
Grant dateMar 12, 2024
Priority date
Expiry dateFeb 3, 2042

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/502
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Methods and systems for screening therapeutic compositions for the treatment of age-related macular degeneration (AMD) or for the prevention of progression of AMD, wherein retinal pigment epithelium cells (RPE) are cultured and the level of hypoxia-induced exosome release from the RPE cells is subsequently measured. In the present invention, the level of hypoxia-induced exosome release can be correlated with AMD onset and severity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.